Volume 29, Issue 1 (April 2022)                   J Birjand Univ Med Sci. 2022, 29(1): 50-56 | Back to browse issues page

Research code: 5133
Ethics code: IR.BUMS.REC.1398.244


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bagheri V, Zangooei M. Effect of Hesperetin on the level of reactive oxygen species (ROS) in gastric cancer stem cells: Short Communication. J Birjand Univ Med Sci. 2022; 29 (1) :50-56
URL: http://journal.bums.ac.ir/article-1-2997-en.html
1- Cellular and Molecular Research Center, Department of Medical Immunology, Birjand University of Medical Sciences, Birjand, Iran
2- Department of Biochemistry, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran , zangooei65@gmail.com
Abstract:   (1884 Views)
Intracellular reactive oxygen species (ROS) play an important role in cancer stem cell (CSC) function. Hesperetin (Hst) is a flavonoid that has been shown to affect cellular ROS level. The goal of this study was to investigate the effect of Hst on the level of ROS in gastric CSCs (GCSCs). MTT assay was used to evaluate cell survival. Cellular ROS level was measured using 2′,7′-dichlorofluorescin diacetate by flow cytometry. A significant decrease in the survival of GCSCs treated with Hst was observed. Hst decreased ROS level to about 47% and 40% at concentrations of 200 and 400 mM, respectively. It can be concluded that Hst reduces the survival and ROS level of GCSCs and may be influences the function of these cells such as proliferation and differentiation as well as response to chemotherapy by affecting cellular ROS level.
Full-Text [PDF 474 kb]   (644 Downloads)    
Type of Study: Short Communication | Subject: Biochemistry- Antioxidants
Received: 2021/03/13 | Accepted: 2021/05/2 | ePublished ahead of print: 2021/06/8 | ePublished: 2022/04/4

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Birjand University of Medical Sciences

Designed & Developed by : Yektaweb